The double life of the ribosome: When its protein folding activity supports prion propagation

REFERENCES

• Chattopadhyay S, Das B, Bera AK, Dasgupta D, Dasgupta C. Refolding of denatured lactate dehydrogenase by Escherichia coli ribosomes. Biochem J 1994; 300 (Pt 3):717-21; PMID:8010952; http://dx.doi.org/10.1042/bj3000717
   PubMed Web of Science ®Google Scholar
• Das D, Das A, Samanta D, Ghosh J, Dasgupta S, Bhattacharya A, Basu A, Sanyal S, Das Gupta C. Role of the ribosome in protein folding. Biotechnol J 2008; 3:999-1009; PMID:18702035; http://dx.doi.org/10.1002/biot.200800098
   PubMedGoogle Scholar
• Pechmann S, Willmund F, Frydman J. The ribosome as a hub for protein quality control. Mol Cell 2013; 49:411-21; PMID:23395271; http://dx.doi.org/10.1016/j.molcel.2013.01.020
   PubMed Web of Science ®Google Scholar
• Melnikov S, Ben-Shem A, Garreau de Loubresse N, Jenner L, Yusupova G, Yusupov M. One core, two shells: bacterial and eukaryotic ribosomes. Nat Struct Mol Biol 2012; 19:560-7; PMID:22664983; http://dx.doi.org/10.1038/nsmb.2313
   PubMed Web of Science ®Google Scholar
• Basu A, Samanta D, Bhattacharya A, Das A, Das D, Dasgupta C. Protein folding following synthesis in vitro and in vivo: association of newly synthesized protein with 50S subunit of E. coli ribosome. Biochem Biophys Res Commun 2008; 366:592-7; http://dx.doi.org/10.1016/j.bbrc.2007.11.142
   PubMed Web of Science ®Google Scholar
• Blondel M, Soubigou F, Evrard J, Nguyen PH, Hasin N, Chedin S, Gillet R, Contesse MA, Friocourt G, Stahl G, et al. Protein Folding Activity of the Ribosome is involved in Yeast Prion Propagation. Sci Rep 2016; 6:32117; PMID:27633137; http://dx.doi.org/10.1038/srep32117
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Pal S, Pal D, Sarkar D, Chandra S, Das Gupta C. Protein folding in Escherichia coli: role of 23S ribosomal RNA. Biochim Biophys Acta 1999; 1429:293-8; PMID:9989214; http://dx.doi.org/10.1016/S0167-4838(98)00179-4
   PubMed Web of Science ®Google Scholar
• Tribouillard-Tanvier D, Dos Reis S, Gug F, Voisset C, Beringue V, Sabate R, Kikovska E, Talarek N, Bach S, Huang C, et al. Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs. PLoS One 2008; 3:e2174; PMID:18478094; http://dx.doi.org/10.1371/journal.pone.0002174
   PubMed Web of Science ®Google Scholar
• Pang Y, Kurella S, Voisset C, Samanta D, Banerjee D, Schabe A, Das Gupta C, Galons H, Blondel M, Sanyal S. The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition. J Biol Chem 2013; 288:19081-9; PMID:23673663; http://dx.doi.org/10.1074/jbc.M113.466748
   PubMed Web of Science ®Google Scholar
• Samanta D, Mukhopadhyay D, Chowdhury S, Ghosh J, Pal S, Basu A, Bhattacharya A, Das A, Das D, DasGupta C. Protein folding by domain V of Escherichia coli 23S rRNA: specificity of RNA-protein interactions. J Bacteriol 2008; 190:3344-52; PMID:18310328; http://dx.doi.org/10.1128/JB.01800-07
   PubMed Web of Science ®Google Scholar
• Pal S, Chandra S, Chowdhury S, Sarkar D, Ghosh AN, Gupta CD. Complementary role of two fragments of domain V of 23 S ribosomal RNA in protein folding. J Biol Chem 1999; 274:32771-7; PMID:10551837; http://dx.doi.org/10.1074/jbc.274.46.32771
   PubMed Web of Science ®Google Scholar
• Mondal S, Pathak BK, Ray S, Barat C. Impact of P-Site tRNA and antibiotics on ribosome mediated protein folding: studies using the Escherichia coli ribosome. PLoS One 2014; 9:e101293; PMID:25000563; http://dx.doi.org/10.1371/journal.pone.0101293
   PubMedGoogle Scholar
• Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, Galons H, Dormont D, Meijer L, Cullin C, Blondel M. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat Biotechnol 2003; 21:1075-81; PMID:12910243; http://dx.doi.org/10.1038/nbt855
   PubMed Web of Science ®Google Scholar
• Tribouillard-Tanvier D, Beringue V, Desban N, Gug F, Bach S, Voisset C, Galons H, Laude H, Vilette D, Blondel M. Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. PLoS One 2008; 3:e1981; PMID:18431471; http://dx.doi.org/10.1371/journal.pone.0001981
   PubMed Web of Science ®Google Scholar
• Oumata N, Nguyen PH, Beringue V, Soubigou F, Pang Y, Desban N, Massacrier C, Morel Y, Paturel C, Contesse MA, et al. The toll-like receptor agonist imiquimod is active against prions. PLoS One 2013; 8:e72112; PMID:23977222; http://dx.doi.org/10.1371/journal.pone.0072112
   PubMed Web of Science ®Google Scholar
• Jones GW, Tuite MF. Chaperoning prions: the cellular machinery for propagating an infectious protein? Bioessays 2005; 27:823-32; PMID:16015602; http://dx.doi.org/10.1002/bies.20267
   PubMed Web of Science ®Google Scholar
• Gloge F, Becker AH, Kramer G, Bukau B. Co-translational mechanisms of protein maturation. Curr Opin Struct Biol 2014; 24:24-33; PMID:24721450; http://dx.doi.org/10.1016/j.sbi.2013.11.004
   PubMed Web of Science ®Google Scholar
• Atkins JF, Gesteland RF, Cech TR (eds.). The RNA worlds: From life's origins to diversity in gene regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2011.
   Google Scholar
• Jeffares DC, Poole AM, Penny D. Relics from the RNA world. J Mol Evol 1998; 46:18-36; PMID: 9419222; http://dx.doi.org/10.1007/PL00006280
   PubMed Web of Science ®Google Scholar
• Nissen P, Hansen J, Ban N, Moore PB, Steitz TA. The structural basis of ribosome activity in peptide bond synthesis. Science 2000; 289:920-30; PMID: 10937990; http://dx.doi.org/10.1126/science.289.5481.920
   PubMed Web of Science ®Google Scholar
• Krupkin M, Matzov D, Tang H, Metz M, Kalaora R, Belousoff MJ, Zimmerman E, Bashan A, Yonath A. A vestige of a prebiotic bonding machine is functioning within the contemporary ribosome. Philos Trans R Soc Lond B Biol Sci 2011; 366:2972-8; PMID:21930590; http://dx.doi.org/10.1098/rstb.2011.0146
   PubMed Web of Science ®Google Scholar
• Reis SD, Pang Y, Vishnu N, Voisset C, Galons H, Blondel M, Sanyal S. Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding. Biochimie 2011; 93:1047-54; PMID:21396977; http://dx.doi.org/10.1016/j.biochi.2011.03.002
   PubMed Web of Science ®Google Scholar
• Mace K, Gillet R. Origins of tmRNA: the missing link in the birth of protein synthesis? Nucleic Acids Res 2016; 44:8041-51; PMID:27484476; http://dx.doi.org/10.1093/nar/gkw693
   PubMed Web of Science ®Google Scholar
• Harish A, Caetano-Anolles G. Ribosomal history reveals origins of modern protein synthesis. PLoS One 2012; 7:e32776; PMID:22427882; http://dx.doi.org/10.1371/journal.pone.0032776
   PubMed Web of Science ®Google Scholar
• Docter BE, Horowitz S, Gray MJ, Jakob U, Bardwell JC. Do nucleic acids moonlight as molecular chaperones? Nucleic Acids Res 2016; 44:4835-45; PMID:27105849; http://dx.doi.org/10.1093/nar/gkw291
   PubMed Web of Science ®Google Scholar
• Reidy M, Masison DC. Yeast prions help identify and define chaperone interaction networks. Curr Pharm Biotechnol 2014; 15:1008-18; PMID:25373385; http://dx.doi.org/10.2174/1389201015666141103021035
   PubMed Web of Science ®Google Scholar
• Hines JK, Li X, Du Z, Higurashi T, Li L, Craig EA. [SWI], the prion formed by the chromatin remodeling factor Swi1, is highly sensitive to alterations in Hsp70 chaperone system activity. PLoS Genet 2011; 7:e1001309; PMID:21379326; http://dx.doi.org/10.1371/journal.pgen.1001309
   PubMed Web of Science ®Google Scholar
• Schwimmer C, Masison DC. Antagonistic interactions between yeast [PSI(+)] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p. Mol Cell Biol 2002; 22:3590-8; PMID:11997496; http://dx.doi.org/10.1128/MCB.22.11.3590-3598.2002
   PubMed Web of Science ®Google Scholar
• Chernoff YO, Newnam GP, Kumar J, Allen K, Zink AD. Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion. Mol Cell Biol 1999; 19:8103-12; PMID:10567536; http://dx.doi.org/10.1128/MCB.19.12.8103
   PubMed Web of Science ®Google Scholar
• Kiktev DA, Melomed MM, Lu CD, Newnam GP, Chernoff YO. Feedback control of prion formation and propagation by the ribosome-associated chaperone complex. Mol Microbiol 2015; 96:621-32; PMID:25649498; http://dx.doi.org/10.1111/mmi.12960
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728; PMID: 18391177; http://dx.doi.org/10.1152/physrev.00007.2007
   PubMed Web of Science ®Google Scholar
• Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, et al. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun 2011; 2:281; PMID:21505437; http://dx.doi.org/10.1038/ncomms1282
   PubMed Web of Science ®Google Scholar
• Paquet S, Sabuncu E, Delaunay JL, Laude H, Vilette D. Prion infection of epithelial Rov cells is a polarized event. J Virol 2004; 78:7148-52; PMID:15194791; http://dx.doi.org/10.1128/JVI.78.13.7148-7152.2004
   PubMed Web of Science ®Google Scholar
• Godsave SF, Wille H, Kujala P, Latawiec D, DeArmond SJ, Serban A, Prusiner SB, Peters PJ. Cryo-immunogold electron microscopy for prions: toward identification of a conversion site. J Neurosci 2008; 28:12489-99; PMID:19020041; http://dx.doi.org/10.1523/JNEUROSCI.4474-08.2008
   PubMed Web of Science ®Google Scholar
• Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion. PLoS Pathog 2009; 5:e1000426; PMID:19424437; http://dx.doi.org/10.1371/journal.ppat.1000426
   PubMed Web of Science ®Google Scholar
• Yim YI, Park BC, Yadavalli R, Zhao X, Eisenberg E, Greene LE. The multivesicular body is the major internal site of prion conversion. J Cell Sci 2015; 128:1434-43; PMID:25663703; http://dx.doi.org/10.1242/jcs.165472
   PubMed Web of Science ®Google Scholar
• Miesbauer M, Rambold AS, Winklhofer KF, Tatzelt J. Targeting of the prion protein to the cytosol: mechanisms and consequences. Curr Issues Mol Biol 2010; 12:109-18; PMID:19767654
   PubMed Web of Science ®Google Scholar
• Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB, Lingappa VR. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 1999; 402:822-6; PMID:10617204; http://dx.doi.org/10.1038/45574
   PubMed Web of Science ®Google Scholar
• Martin-Lanneree S, Hirsch TZ, Hernandez-Rapp J, Halliez S, Vilotte JL, Launay JM, Mouillet-Richard S. PrP(C) from stem cells to cancer. Front Cell Dev Biol 2014; 2:55; PMID:25364760
   PubMedGoogle Scholar
• Martins VR, Beraldo FH, Hajj GN, Lopes MH, Lee KS, Prado MA, Linden R. Prion protein: orchestrating neurotrophic activities. Curr Issues Mol Biol 2010; 12:63-86; PMID:19767651
   PubMed Web of Science ®Google Scholar
• Halliez S, Passet B, Martin-Lanneree S, Hernandez-Rapp J, Laude H, Mouillet-Richard S, Vilotte JL, Béringue V. To develop with or without the prion protein. Front Cell Dev Biol 2014; 2:58; PMID:25364763; http://dx.doi.org/10.3389/fcell.2014.00058
   PubMedGoogle Scholar
• Bravard A, Auvre F, Fantini D, Bernardino-Sgherri J, Sissoeff L, Daynac M, Xu Z, Etienne O, Dehen C, Comoy E, et al. The prion protein is critical for DNA repair and cell survival after genotoxic stress. Nucleic Acids Res 2015; 43:904-16; PMID:25539913; http://dx.doi.org/10.1093/nar/gku1342
   PubMed Web of Science ®Google Scholar
• Smith HL, Mallucci GR. The unfolded protein response: mechanisms and therapy of neurodegeneration. Brain 2016; 139:2113-21; PMID:27190028; http://dx.doi.org/10.1093/brain/aww101
   PubMed Web of Science ®Google Scholar
• Mays CE, Kim C, Haldiman T, van der Merwe J, Lau A, Yang J, Grams J, Di Bari MA, Nonno R, Telling GC, et al. Prion disease tempo determined by host-dependent substrate reduction. J Clin Invest 2014; 124:847-58; PMID:24430187; http://dx.doi.org/10.1172/JCI72241
   PubMed Web of Science ®Google Scholar
• Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010; 11:301-7; PMID:20308987; http://dx.doi.org/10.1038/nrm2873
   PubMed Web of Science ®Google Scholar
• Frost B, Diamond MI. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 2010; 11:155-9; PMID:20029438
   PubMed Web of Science ®Google Scholar
• Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010; 33:317-25; PMID:20493564; http://dx.doi.org/10.1016/j.tins.2010.04.003
   PubMed Web of Science ®Google Scholar
• Barbezier N, Chartier A, Bidet Y, Buttstedt A, Voisset C, Galons H, Blondel M, Schwarz E, Simonelig M. Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy. EMBO Mol Med 2011; 3:35-49; PMID:21204267; http://dx.doi.org/10.1002/emmm.201000109
   PubMed Web of Science ®Google Scholar